Denosumab and romosozumab do not increase the risk of...

Bone 2020 / 05 Vol. 134

Denosumab and romosozumab do not increase the risk of cardiovascular events in patients with primary osteoporosis: A reanalysis of the meta-analysis

Li, Lang, Gong, Min, Bao, Dingsu, Sun, Jiachen, Xiang, Zhou
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
134
Journal:
Bone
DOI:
10.1016/j.bone.2020.115270
Date:
May, 2020
File:
PDF, 627 KB
2020
Conversion to is in progress
Conversion to is failed